Second, it has been shown in other models that PD-1 blockade reduces the population of highly immunosuppressive myeloid-derived suppressor cells (MDSC), which inhibit anti-tumor immune responses (John et al., 2013). The gene discussed is PDCD1; the disease is neoplasm.